This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Skyward Specialty Stock Gains 48% YTD: Time to Buy or Hold?
by Zacks Equity Research
Improving top line, expanding margins and sufficient financial flexibility continue to drive SKWD.
Skyward Specialty Insurance Group, Inc. (SKWD) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Root, Inc. (ROOT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Root (ROOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SKWD or KNSL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SKWD vs. KNSL: Which Stock Is the Better Value Option?
Skyward (SKWD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Skyward (SKWD) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Skyward Specialty Insurance (SKWD) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Skyward (SKWD) delivered earnings and revenue surprises of 10.94% and 2.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for These 3 Insurance Stocks in Q3 Earnings?
by Sushmita Sarker
Here, we take a look at three insurance stocks, UNM, CB and SKWD, which are set to report third-quarter earnings on Oct. 29.
Skyward Specialty Insurance Group, Inc. (SKWD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Buy Low-Beta Stocks JD, SKWD, CORT, PRA to Beat Election Uncertainty
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. JD, SKWD, CORT & PRA are well-poised to gain.
Should SKWD Stock Be in Your Portfolio Ahead of Q3 Earnings?
by Tanuka De
Skyward Specialty's third-quarter results are likely to benefit from higher premiums and net investment income.
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Best Value Stocks to Buy for October 23rd
by Zacks Equity Research
GTEC, RUSHA and SKWD made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 23, 2024.
Skyward Specialty Insurance (SKWD) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Skyward (SKWD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Skyward (SKWD) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Skyward (SKWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SKWD vs. KNSL: Which Stock Is the Better Value Option?
by Zacks Equity Research
SKWD vs. KNSL: Which Stock Is the Better Value Option?
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will Skyward (SKWD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Skyward Specialty Insurance Group, Inc. (SKWD) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Skyward Specialty Near 52-Week High: Should You Buy the Stock?
by Tanuka De
The positive analyst sentiment surrounding the stock, the company's growth prospects and its VGM Score of B make SKWD a solid investment bet.
5 Top Red-Hot Stocks to Buy Now
by Tracey Ryniec
he hottest stocks might not be those you think. Look past AI and technology stocks.
Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Time to Buy These Top Insurance Stocks Amid Heightened Market Volatility
by Shaun Pruitt
Amid heightened market volatility investors may want to consider several insurance stocks that have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.
What Makes Skyward Specialty Insurance (SKWD) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Skyward Specialty Insurance (SKWD) have what it takes to be a top stock pick for momentum investors? Let's find out.
SKWD vs. PGR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SKWD vs. PGR: Which Stock Is the Better Value Option?
Is Skyward Specialty Insurance Group, Inc. (SKWD) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Skyward Specialty Insurance (SKWD) and The Bank of New York Mellon Corporation (BK) have performed compared to their sector so far this year.